Aloe vera: A review of toxicity and adverse clinical effects

Journal of Environmental Science and Health - Part C Environmental Carcinogenesis and Ecotoxicology Reviews

Volumn 34, Issue 2, 2016, Pages 77-96

  Guo, Xiaoqing ^a   Mei, Nan ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Aloe gel; aloe latex; Aloe vera; carcinogenicity; genotoxicity; toxicological effects

Indexed keywords

CHEMICAL ANALYSIS; DIETARY SUPPLEMENTS; INDICATORS (CHEMICAL); INTERNATIONAL COOPERATION; KETONES;

ALOE VERA; CARCINOGENIC ACTIVITY; CARCINOGENICITY; GENOTOXICITIES; HYPERSENSITIVE REACTION; INTERNATIONAL AGENCY FOR RESEARCH ON CANCERS; TOXICOLOGICAL EFFECTS; UPDATED INFORMATIONS;

LATEXES;

ALOE VERA EXTRACT; LATEX; ANTHRAQUINONE DERIVATIVE; CARCINOGEN; COSMETIC; PLANT EXTRACT; POLYSACCHARIDE;

ADVERSE OUTCOME; ALOE VERA; ARTICLE; CARCINOGENESIS; CARCINOGENICITY; CHEMICAL COMPOSITION; CYTOTOXICITY; DRUG EFFECT; EXUDATE; GEL; GENOTOXICITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PLANT LEAF; SIDE EFFECT; ADVERSE DRUG REACTION; ALOE; ANIMAL; DNA DAMAGE; TOXICITY;

ALOE; ANIMALS; ANTHRAQUINONES; CARCINOGENESIS; CARCINOGENS; COSMETICS; DNA DAMAGE; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; PLANT EXTRACTS; POLYSACCHARIDES;

EID: 84974808205     PISSN: 10590501     EISSN: 15324095     Source Type: Journal    
DOI: 10.1080/10590501.2016.1166826     Document Type: Article

References (99)

1. P.M.Barnes, B.Bloom, R.L.Nahin. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report. 2008;12:1–23.
2. R.L.Nahin, P.M.Barnes, B.J.Stussman, B.Bloom. Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. Natl Health Stat Report. 2009;18:1–14.
3. Cosmetic Ingredient Review Expert Panel (CIR). Final report on the safety assessment of aloe andongensis extract, aloe andongensis leaf juice, aloe arborescens leaf extract, aloe arborescens leaf juice, aloe arborescens leaf protoplasts, aloe barbadensis flower extract, aloe barbadensis leaf, aloe barbadensis leaf extract, aloe barbadensis leaf juice, aloe barbadensis leaf polysaccharides, aloe barbadensis leaf water, aloe ferox leaf extract, aloe ferox leaf juice, and aloe ferox leaf juice extract. Int J Toxicol. 2007;26(Suppl 2):1–50.
4. E.Rodriguez Rodriguez, J.Darias Martin, C.Diaz Romero. Aloe vera as a functional ingredient in foods. Crit Rev Food Sci Nutr. 2010;50:305–326.
5. M.D.Boudreau, F.A.Beland. An evaluation of the biological and toxicological properties of Aloe barbadensis (miller), Aloe vera. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2006;24:103–154.
6. Y.Ni, D.Turner, K.M.Yates, I.Tizard. Isolation and characterization of structural components of Aloe vera L. leaf pulp. Int Immunopharmacol. 2004;4:1745–1755.
7. D.Grindlay, T.Reynolds. The Aloe vera phenomenon: A review of the properties and modern uses of the leaf parenchyma gel. J Ethnopharmacol. 1986;16:117–151.
8. P.Atherton Aloe vera: Magic or medicine? Nurs Stand. 1998;12:49–54.
9. T.Reynolds, A.C.Dweck. Aloe vera leaf gel: A review update. J Ethnopharmacol. 1999;68:3–37.
10. A.Atiba, M.Nishimura, S.Kakinuma, T.Hiraoka, M.Goryo, Y.Shimada, H.Ueno, Y.Uzuka. Aloe vera oral administration accelerates acute radiation-delayed wound healing by stimulating transforming growth factor-beta and fibroblast growth factor production. Am J Surg. 2011;201:809–818.
11. M.Foster, D.Hunter, S.Samman. Evaluation of the nutritional and metabolic effects of Aloe vera. In: I.F.F.Benzie, S.Wachtel-Galor, eds., Herbal Medicine: Biomolecular and Clinical Aspects. 2nd ed., CRC Press, Boca Raton, FL; 2011:Chapter 3. http://www.ncbi.nlm.nih.gov/books/NBK92765/ (accessed October, 2015).
12. B.K.Vogler, E.Ernst. Aloe vera: A systematic review of its clinical effectiveness. Br J Gen Pract. 1999;49:823–828.
13. M.Tanaka, M.Yamada, T.Toida, K.Iwatsuki. Safety evaluation of supercritical carbon dioxide extract of Aloe vera gel. J Food Sci. 2012;77:T2–9.
14. US Food and Drug Administration. Status of certain additional over-the-counter drug category II and III active ingredients. Fed Regist. 2002;67:31125–31127.
15. Y.Grosse, D.Loomis, B.Lauby-Secretan, F.El Ghissassi, V.Bouvard, L.Benbrahim-Tallaa, N.Guha, R.Baan, H.Mattock, K.Straif, and International Agency for Research on Cancer Monograph Working Group. Carcinogenicity of some drugs and herbal products. Lancet Oncology. 2013;14:807–808.
16. International Agency for Research on Cancer. Aloe vera. In: Some Drugs and Herbal Products (Volume 108), International Agency for research on Cancer, Lyon, France; 2015. http://monographs.iarc.fr/ENG/Monographs/vol108/mono108.pdf (accessed October, 2015).
17. Q.Xia, J.J.Yin, P.P.Fu, M.D.Boudreau. Photo-irradiation of Aloe vera by UVA—Formation of free radicals, singlet oxygen, superoxide, and induction of lipid peroxidation. Toxicol Lett. 2007;168:165–175.
18. X.Guo, S.Zhang, S.L.Dial, M.D.Boudreau, Q.Xia, P.P.Fu, D.D.Levy, M.M.Moore, N.Mei. In vitro investigation of the mutagenic potential of Aloe vera extracts. Toxicol Res. 2014;3:487–496.
19. A.Logarto Parra, R.Silva Yhebra, I.Guerra Sardinas, L.Iglesias Buela. Comparative study of the assay of Artemia salina L. and the estimate of the medium lethal dose (LD50 value) in mice, to determine oral acute toxicity of plant extracts. Phytomedicine. 2001;8:395–400.
20. M.L.Dhar, M.M.Dhar, B.N.Dhawan, B.N.Mehrotra, C.Ray. Screening of Indian plants for biological activity: I. Indian J Exp Biol. 1968;6:232–247.
21. L.H.du Plessis, J.H.Hamman. In vitro evaluation of the cytotoxic and apoptogenic properties of aloe whole leaf and gel materials. Drug Chem Toxicol. 2014;37:169–177.
22. Y.Zhou, Y.Feng, H.Wang, H.Yang. 90-day subchronic toxicity study of aloe whole-leaf powder. Wei Sheng Yan Jiu. 2003;32:590–593.
23. A.H.Shah, S.Qureshi, M.Tariq, A.M.Ageel. Toxicity studies on six plants used in the traditional Arab system of medicine. Phytotherapy Res. 1989;3:25–29.
24. M.D.Boudreau, F.A.Beland, J.A.Nichols, M.Pogribna. Toxicology and carcinogenesis studies of a nondecolorized whole leaf extract of Aloe barbadensis Miller (Aloe vera) in F344/N rats and B6C3F1 mice (drinking water study). Natl Toxicol Program Tech Rep Ser. 2013;577:1–266.
25. A.Shao, A.Broadmeadow, G.Goddard, V.Bejar E Frankos. Safety of purified decolorized (low anthraquinone) whole leaf Aloe vera (L) Burm. f. juice in a 3-month drinking water toxicity study in F344 rats. Food Chem Toxicol. 2013;57:21–31.
26. I.Sehgal, W.D.Winters, M.Scott, A.David, G.Gillis, T.Stoufflet, A.Nair, K.Kousoulas Toxicologic assessment of a commercial decolorized whole leaf aloe vera juice, lily of the desert filtered whole leaf juice with aloesorb. J Toxicol. 2013:802453.
27. I.Morimoto, F.Watanabe, T.Osawa, T.Okitsu, T.Kada. Mutagenicity screening of crude drugs with Bacillus subtilis rec-assay and Salmonella/microsome reversion assay. Mutat Res. 1982;97:81–102.
28. National Toxicology Program. Toxicology and carcinogenesis studies of a nondecolorized whole leaf extract of Aloe vera in F344/N rats and B6C3F1 mice. http://ntp.niehs.nih.gov/ntp/htdocs/lt_rpts/tr577_508.pdf (accessed October, 2015).
29. M.D.Boudreau, P.W.Mellick, G.R.Olson, R.P.Felton, B.T.Thorn, F.A.Beland. Clear evidence of carcinogenic activity by a whole-leaf extract of Aloe barbadensis miller (aloe vera) in F344/N rats. Toxicol Sci. 2013;131:26–39.
30. Y.Matsuda, M.Yokohira, S.Suzuki, K.Hosokawa, K.Yamakawa, Y.Zeng, F.Ninomiya, K.Saoo, T.Kuno, K.Imaida. One-year chronic toxicity study of Aloe arborescens Miller var. natalensis Berger in Wistar Hannover rats. A pilot study. Food Chem Toxicol 2008;46:733–739.
31. M.Yokohira, Y.Matsuda, S.Suzuki, K.Hosokawa, K.Yamakawa, N.Hashimoto, K.Saoo, K.Nabae, Y.Doi, T.Kuno, K.Imaida. Equivocal colonic carcinogenicity of Aloe arborescens Miller var. natalensis berger at high-dose level in a Wistar Hannover rat 2-y study. J Food Sci. 2009;74:T24–30.
32. P.P.Fu, Q.Xia, Y.Zhao, S.Wang, H.Yu, H.M.Chiang. Phototoxicity of herbal plants and herbal products. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2013;31:213–255.
33. National Toxicology Program. Photocarcinogenesis study of aloe vera [CAS NO. 481-72-1(Aloe-emodin)] in SKH-1 mice (simulated solar light and topical application study). Natl Toxicol Program Tech Rep Ser. 2010;553:7–103.
34. V.Steenkamp, M.J.Stewart. Medicinal applications and toxicological activities of Aloe products. Pharm Bio. 2007;45:411–420.
35. A.Lee, P.T.Chui, C.S.Aun, T.Gin, A.S.Lau. Possible interaction between sevoflurane and Aloe vera. Ann Pharmacother. 2004;38:1651–1654.
36. V.A.Luyckx, R.Ballantine, M.Claeys, F.Cuyckens, H.Van den Heuvel, R.K.Cimanga, A.J.Vlietinck, M.E.De Broe, I.J.Katz. Herbal remedy-associated acute renal failure secondary to Cape aloes. Am J Kidney Dis. 2002;39:E13.
37. L.Guo, N.Mei, Q.Xia, T.Chen, P.C.Chan, P.P.Fu. Gene expression profiling as an initial approach for mechanistic studies of toxicity and tumorigenicity of herbal plants and herbal dietary supplements. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2010;28:60–87.
38. C.Rabe, A.Musch, P.Schirmacher, W.Kruis, R.Hoffmann. Acute hepatitis induced by an Aloe vera preparation: a case report. World J Gastroenterol. 2005;11:303–304.
39. O.Kanat, A.Ozet, S.Ataergin. Aloe vera-induced acute toxic hepatitis in a healthy young man. Eur J Intern Med. 2006;17:589.
40. M.M.Bottenberg, G.C.Wall, R.L.Harvey, S.Habib. Oral aloe vera-induced hepatitis. Ann Pharmacother. 2007;41:1740–1743.
41. J.Curciarello, S.De Ortuzar, S.Borzi, D.Bosia. Severe acute hepatitis associated with intake of Aloe vera tea. Gastroenterol Hepatol. 2008;31:436–438.
42. H.N.Yang, D.J.Kim, Y.M.Kim, B.H.Kim, K.M.Sohn, M.J.Choi, Y.H.Choi. Aloe-induced toxic hepatitis. J Korean Med Sci. 2010;25:492–495.
43. J.Lee, M.S.Lee, K.W.Nam. Acute toxic hepatitis caused by an aloe vera preparation in a young patient: a case report with a literature review. Korean J Gastroenterol. 2014;64:54–58.
44. M.K.Park, J.H.Park, N.Y.Kim, Y.G.Shin, Y.S.Choi, J.G.Lee, K.H.Kim, S.K.Lee. Analysis of 13 phenolic compounds in aloe species by high performance liquid chromatography. Phytochemi Anal. 1998;9:186–191.
45. W.Rebecca, O.Kayser, H.Hagels, K.H.Zessin, M.Madundo, N.Gamba. The phytochemical profile and identification of main phenolic compounds from the leaf exudate of Aloe secundiflora by high-performance liquid chromatography-mass spectroscopy. Phytochem Anal. 2003;14:83–86.
46. T.Reynolds Observations on the phytochemistry of the Aloe leaf-exudate compounds. Bot J Linn Soc. 1985;90:179–199.
47. D.Saccu, P.Bogoni, G.Procida. Aloe exudate: characterization by reversed phase HPLC and headspace GC-MS. J Agric Food Chem. 2001;49:4526–4530.
48. J.G.Lin, G.W.Chen, T.M.Li, S.T.Chouh, T.W.Tan, J.G.Chung. Aloe-emodin induces apoptosis in T24 human bladder cancer cells through the p53 dependent apoptotic pathway. J Urol. 2006;175:343–347.
49. H.C.Chen, W.T.Hsieh, W.C.Chang, J.G.Chung. Aloe-emodin induced in vitro G2/M arrest of cell cycle in human promyelocytic leukemia HL-60 cells. Food Chem Toxicol. 2004;42:1251–1257.
50. H.Z.Lee Protein kinase C involvement in aloe-emodin- and emodin-induced apoptosis in lung carcinoma cell. Br J Pharmacol. 2001;134:1093–1103.
51. D.Popadic, E.Savic, Z.Ramic, V.Djordjevic, V.Trajkovic, L.Medenica, S.Popadic. Aloe-emodin inhibits proliferation of adult human keratinocytes in vitro. J Cosmet Sci. 2012;63:297–302.
52. E.J.Buenz Aloin induces apoptosis in Jurkat cells. Toxicol In Vitro. 2008;22:422–429.
53. M.Yimam, L.Brownell, Q.Jia. In vivo safety evaluation of UP780, a standardized composition of aloe chromone aloesin formulated with an Aloe vera inner leaf fillet. Regul Toxicol Pharmacol. 2014;69:390–397.
54. J.P.Brown, P.S.Dietrich, R.J.Brown. Frameshift mutagenicity of certain naturally occurring phenolic compounds in the ‘Salmonella/microsome’ test: Activation of anthraquinone and flavonol glycosides by gut bacterial enzymes. Biochem Soc Trans. 1977;5:1489–1492.
55. J.Westendorf, H.Marquardt, B.Poginsky, M.Dominiak, J.Schmidt. Genotoxicity of naturally occurring hydroxyanthraquinones. Mutat Res. 1990;240:1–12.
56. F.Nesslany, S.Simar-Meintieres, H.Ficheux, D.Marzin. Aloe-emodin-induced DNA fragmentation in the mouse in vivo comet assay. Mutat Res. 2009;678:13–19.
57. A.Heidemann, W.Volkner, U.Mengs. Genotoxicity of aloeemodin in vitro and in vivo. Mutat Res. 1996;367:123–133.
58. S.O.Muller, I.Eckert, W.K.Lutz, H.Stopper. Genotoxicity of the laxative drug components emodin, aloe-emodin and danthron in mammalian cells: topoisomerase II mediated? Mutat Res. 1996;371:165–173.
59. S.O.Mueller, H.Stopper. Characterization of the genotoxicity of anthraquinones in mammalian cells. Biochim Biophys Acta. 1999;1428:406–414.
60. Y.Li, Y.Luan, X.Qi, M.Li, L.Gong, X.Xue, X.Wu, Y.Wu, M.Chen, G.Xing, J.Yao, J.Ren. Emodin triggers DNA double-strand breaks by stabilizing topoisomerase II-DNA cleavage complexes and by inhibiting ATP hydrolysis of topoisomerase II. Toxicol Sci. 2010;118:435–443.
61. H.Z.Lee, C.J.Lin, W.H.Yang, W.C.Leung, S.P.Chang. Aloe-emodin induced DNA damage through generation of reactive oxygen species in human lung carcinoma cells. Cancer Lett. 2006;239:55–63.
62. J.H.Chiang, J.S.Yang, C.Y.Ma, M.D.Yang, H.Y.Huang, T.C.Hsia, H.M.Kuo, P.P.Wu, T.H.Lee, J.G.Chung. Danthron, an anthraquinone derivative, induces DNA damage and caspase cascades-mediated apoptosis in SNU-1 human gastric cancer cells through mitochondrial permeability transition pores and Bax-triggered pathways. Chem Res Toxicol. 2011;24:20–29.
63. D.Wolfle, C.Schmutte, J.Westendorf, H.Marquardt. Hydroxyanthraquinones as tumor promoters: Enhancement of malignant transformation of C3H mouse fibroblasts and growth stimulation of primary rat hepatocytes. Cancer Res. 1990;50:6540–6544.
64. H.Mori, N.Yoshimi, H.Iwata, Y.Mori, A.Hara, T.Tanaka, K.Kawai. Carcinogenicity of naturally occurring 1-hydroxyanthraquinone in rats: Induction of large bowel, liver and stomach neoplasms. Carcinogenesis. 1990;11:799–802.
65. National Toxicology Program. NTP Toxicology and Carcinogenesis Studies of emodiN (CAS NO. 518-82-1) feed studies in F344/N rats and B6C3F1 mice. Natl Toxicol Program Tech Rep Ser. 2001;493:1–278.
66. F.M.Strickland, H.K.Muller, L.C.Stephens, C.D.Bucana, C.K.Donawho, Y.Sun, R.P.Pelley. Induction of primary cutaneous melanomas in C3H mice by combined treatment with ultraviolet radiation, ethanol and aloe emodin. Photochem Photobiol. 2000;72:407–414.
67. B.Fantus Aloes as a medicine. J Am Pharm Assoc. 1922;11:616–619.
68. B.A.van Gorkom, E.G.de Vries, A.Karrenbeld, J.H.Kleibeuker. Review article: Anthranoid laxatives and their potential carcinogenic effects. Aliment Pharmacol Ther. 1999;13:443–452.
69. E.Cholongitas, S.Katsoudas, S.Dourakis. Henoch-Schonlein purpura associated with Aloe vera administration. Eur J Intern Med. 2005;16:59–60.
70. A.Abendroth, R.Klein, J.Schlaak, K.A.Metz, G.J.Dobos, J.Langhorst. Impressive picture of a melanosis coli after chronic anthraquinone laxative use—Is there an increased risk for colorectal cancer? Z Gastroenterol. 2009;47:579–582.
71. P.M.Patel, P.J.Selby, J.Deacon, C.Chilvers, T.J.McElwain. Anthraquinone laxatives and human cancer: an association in one case. Postgrad Med J. 1989;65:216–217.
72. A.Femenia, E.S.Sánchez, S.Simal, C.Rosselló. Compositional features of polysaccharides from Aloe vera (Aloe barbadensis Miller) plant tissues. Carbohydr Polymers. 1999;39:109–117.
73. J.H.Hamman Composition and applications of Aloe vera leaf gel. Molecules. 2008;13:1599–1616.
74. Y.-T.Wang, K.J.Strong. A two-year study monitoring several physical and chemical properties of field-grown Aloe barbadensis Miller leaves. Subtropical Plant Sci. 1995;47:34–38.
75. J.Tai-Nin Chow, D.A.Williamson, K.M.Yates, W.J.Goux. Chemical characterization of the immunomodulating polysaccharide of Aloe vera L. Carbohydr Res. 2005;340:1131–1142.
76. G.D.Mandal, Amalendu Structure of the glucomannan isolated from the leaves of Aloe barbadensis Miller. Carbohydr Res. 1980;87:249–256.
77. A.Yaron Characterization of Aloe vera gel before and after autodegradation, and stabilization of the natural fresh gel. Phytother Res. 1993;7:S11–S13.
78. H.Avila, J.Rivero, F.Herrera, G.Fraile. Cytotoxicity of a low molecular weight fraction from Aloe vera (Aloe barbadensis Miller) gel. Toxicon. 1997;35:1423–1430.
79. S.Asgharzade, M.Rafieian-Kopaei, A.Mirzaeian, S.Reiisi and L.Salimzadeh. Aloe vera toxic effects: expression of inducible nitric oxide synthase (iNOS) in testis of Wistar rat. Iran J Basic Med Sci. 2015;38:967–973.
80. I.Sehgal, W.D.Winters, M.Scott, K.Kousoulas. An in vitro and in vivo toxicologic evaluation of a stabilized aloe vera gel supplement drink in mice. Food Chem Toxicol. 2013;55:363–370.
81. J.T.Herlihy, H.A.Bertrand, J.D.Kim, Y.Ikeno, B.P.Yu. Effects of Aloe vera ingestion in the rat. I. Growth, food and fluid intake and serum chemistry. Phytotherapy Res. 1998;12:183–188.
82. Y.Ikeno, G.B.Hubbard, S.Lee, B.P.Yu, J.T.Herlihy. The influence of long-term Aloe vera ingestion on age-related disease in male Fischer 344 rats. Phytother Res. 2002;16:712–718.
83. A.A.Paes-Leme, E.S.Motta, J.C.De Mattos, F.J.Dantas, R.J.Bezerra, A.Caldeira-de-Araujo. Assessment of Aloe vera (L.) genotoxic potential on Escherichia coli and plasmid DNA. J Ethnopharmacol. 2005;102:197–201.
84. L.D.Williams, G.A.Burdock, E.Shin, S.Kim, T.H.Jo, K.N.Jones, R.A.Matulka. Safety studies conducted on a proprietary high-purity aloe vera inner leaf fillet preparation, Qmatrix. Regul Toxicol Pharmacol. 2010;57:90–98.
85. V.Visuthikosol, B.Chowchuen, Y.Sukwanarat, S.Sriurairatana, V.Boonpucknavig. Effect of aloe vera gel to healing of burn wound a clinical and histologic study. J Med Assoc Thai. 1995;78:403–409.
86. R.L.Reddy, R.S.Reddy, T.Ramesh, T.R.Singh, L.A.Swapna, N.V.Laxmi. Randomized trial of aloe vera gel vs triamcinolone acetonide ointment in the treatment of oral lichen planus. Quintessence Int. 2012;43:793–800.
87. H.F.Huseini, S.Kianbakht, R.Hajiaghaee, F.H.Dabaghian. Anti-hyperglycemic and anti-hypercholesterolemic effects of Aloe vera leaf gel in hyperlipidemic type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial. Planta Med. 2012;78:311–316.
88. N.Babaee, E.Zabihi, S.Mohseni, A.A.Moghadamnia. Evaluation of the therapeutic effects of Aloe vera gel on minor recurrent aphthous stomatitis. Dent Res J (Isfahan). 2012;9:381–385.
89. D.M.Morrow, M.J.Rapaport, R.A.Strick. Hypersensitivity to aloe. Arch Dermatol. 1980;116:1064–1065.
90. M.Ferreira, M.Teixeira, E.Silva, M.Selores. Allergic contact dermatitis to Aloe vera. Contact Dermatitis. 2007;57:278–279.
91. D.Hunter, A.Frumkin. Adverse reactions to vitamin E and aloe vera preparations after dermabrasion and chemical peel. Cutis. 1991;47:193–196.
92. R.L.Bailey, J.J.Gahche, C.V.Lentino, J.T.Dwyer, J.S.Engel, P.R.Thomas, J.M.Betz, C.T.Sempos, M.F.Picciano. Dietary supplement use in the United States, 2003–2006. J Nutr. 2011;141:261–266.
93. L.Guo, J.C.Fuscoe, P.P.Fu, Mei N. Application of DNA microarray in studies of herbal dietary supplements. In: D.A.Casciano, S.C.Sahu, eds., Handbook of Systems Toxicology, John Wiley & Sons Ltd., Chichester, UK;2011:407–418.
94. C.Ceccaroli, A.Pulliero, M.Geretto, A.Izzotti Molecular fingerprints of environmental carcinogens in human cancer. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2015;33:188–228.
95. B.Ning, Z.Su, N.Mei, H.Hong, H.Deng, L.Shi, J.C.Fuscoe, W.H.Tolleson. Toxicogenomics and cancer susceptibility: advances with next-generation sequencing. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2014;32:121–158.
96. J.Ruan, H.Gao, N.Li, J.Xue, J.Chen, C.Ke, Y.Ye, P.P.Fu, J.Zheng, J.Wang, G.Lin Blood Pyrrole-Protein Adducts-A Biomarker of Pyrrolizidine Alkaloid-Induced Liver Injury in Humans. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2015;33:404–421.
97. D.S.Goldberg, K.A.Forde, D.M.Carbonari, J.D.Lewis, K.B.Leidl, K.R.Reddy, K.Haynes, J.Roy, D.Sha, A.R.Marks, J.L.Schneider, B.L.Strom, D.A.Corley, V.Lo Re, 3rd. Population-representative incidence of drug-induced acute liver failure based on an analysis of an integrated health care system. Gastroenterology. 2015;148:1353–1361.
98. C.Owens, R.Baergen, D.Puckett. Online sources of herbal product information. Am J Med. 2014;127:109–115.
99. S.Dentali “Nondecolorized” essential qualifier for NTP aloe vera study material. Toxicol Sci. 2013;133:342.